| 臺大學術典藏 |
2021-02-01T07:30:36Z |
Laparo-endoscopic single-site (LESS) bilateral nephroureterectomy for patients with end-stage renal disease
|
Chung S.-D.;Tsai Y.-C.;Shuo-Meng Wang;Hung S.-F.;Huang C.-Y.;Chueh S.-C.;Yu H.-J.; Chung S.-D.; Tsai Y.-C.; SHUO-MENG WANG; Hung S.-F.; Huang C.-Y.; Chueh S.-C.; Yu H.-J. |
| 臺大學術典藏 |
2021-02-01T07:30:35Z |
Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
|
Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.; Hung S.-C.; Wu V.-C.; Wu K.-D.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; SHUO-MENG WANG; Huang K.-H.; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Chueh S.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-02-01T07:30:30Z |
Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
|
Hu C.-Y.;Tsai Y.-C.;Shuo-Meng Wang;Huang C.-Y.;Tai H.-C.;Chen C.-H.;Pu Y.-S.;Lin W.-C.;Huang K.-H.; Hu C.-Y.; Tsai Y.-C.; SHUO-MENG WANG; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; Lin W.-C.; Huang K.-H. |
| 臺大學術典藏 |
2021-02-01T07:30:29Z |
Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population
|
Wu V.-C.;Huang K.-H.;Peng K.-Y.;Tsai Y.-C.;Wu C.-H.;Shuo-Meng Wang;Yang S.-Y.;Lin L.-Y.;Chang C.-C.;Lin Y.-H.;Lin S.-L.;Chu T.-S.;Wu K.-D.; Wu V.-C.; Huang K.-H.; Peng K.-Y.; Tsai Y.-C.; Wu C.-H.; SHUO-MENG WANG; Yang S.-Y.; Lin L.-Y.; Chang C.-C.; Lin Y.-H.; Lin S.-L.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-02-01T07:30:26Z |
Arterial stiffness and blood pressure improvement in aldosterone-producing adenoma harboring KCNJ5 mutations after adrenalectomy
|
Chang C.-H.;Hu Y.-H.;Tsai Y.-C.;Wu C.-H.;Shuo-Meng Wang;Lin L.-Y.;Lin Y.-H.;Satoh F.;Wu K.-D.;Wu V.-C.; Chang C.-H.; Hu Y.-H.; Tsai Y.-C.; Wu C.-H.; SHUO-MENG WANG; Lin L.-Y.; Lin Y.-H.; Satoh F.; Wu K.-D.; Wu V.-C. |
| 臺大學術典藏 |
2021-02-01T07:30:24Z |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.;Hu Y.-H.;Chen L.;Chang C.-C.;Lin Y.-F.;Lai T.-S.;Huang K.-H.;Lin Y.-H.;Wu V.-C.;Wu K.-D.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Chang C.-H.;Chang Y.-L.;Tsai Y.-C.;Yu C.-C.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Shuo-Meng Wang;Liao S.-C.;Lu C.-C.;Yen R.-F.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; Huang K.-H.; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; SHUO-MENG WANG; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-02-01T07:30:23Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Huang K.-H.;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Shuo-Meng Wang;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; Huang K.-H.; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; SHUO-MENG WANG; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2021-02-01T07:30:22Z |
Plasma Aldosterone after Seated Saline Infusion Test Outperforms Captopril Test at Predicting Clinical Outcomes after Adrenalectomy for Primary Aldosteronism
|
Wu C.-H.;Wu V.;Yang Y.-W.;Lin Y.-H.;Yang S.-Y.;Lin P.-C.;Chang C.-C.;Tsai Y.-C.;Shuo-Meng Wang; Wu C.-H.; Wu V.; Yang Y.-W.; Lin Y.-H.; Yang S.-Y.; Lin P.-C.; Chang C.-C.; Tsai Y.-C.; SHUO-MENG WANG |
| 臺大學術典藏 |
2021-02-01T07:30:21Z |
Transtubular potassium gradient predicts kidney function impairment after adrenalectomy in primary aldosteronism
|
Liao H.-W.; SHUO-MENG WANG; Chan C.-K.; Lin Y.-H.; Lin P.-C.; Ho C.-H.; Liu Y.-C.; Chueh J.S.; Wu V.-C.; Lai T.-S.; Yang S.-Y.; Liu K.-L.; Chang C.-C.; Lee B.-C.; Huang K.-H.; Lin L.-Y.; Liao S.-C.; Yen R.-F.; Lu C.-C.; Er L.-K.; Hu Y.-H.; Chang C.-H.; Wu C.-H.; Tsai Y.-C.; Chueh S.-C.J.; Huang W.-C.; Chen Y.-Y.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-29T03:17:19Z |
Laparoendoscopic single-site (LESS) retroperitoneal partial adrenalectomy using a custom-made single-access platform and standard laparoscopic instruments: Technical considerations and surgical outcomes
|
Ho C.-H.;Liao P.-W.;Lin V.C.;Jaw F.-S.;Chueh S.-C.J.;Chung S.-D.;Shih-Ping Liu;Tsai Y.-C.;Yu H.-J.; Ho C.-H.; Liao P.-W.; Lin V.C.; Jaw F.-S.; Chueh S.-C.J.; Chung S.-D.; SHIH-PING LIU; Tsai Y.-C.; Yu H.-J. |
| 臺大學術典藏 |
2021-01-28T02:03:54Z |
Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study
|
Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Keng H.-Y.; Tsai Y.-C.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:03:54Z |
Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens
|
Lin C.-C.; Hsu C.-H.; Huang C.-Y.; Tsai Y.-C.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:03:52Z |
Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer
|
Chen C.-H.;Shun C.-T.;Kuo-How Huang;Huang C.-Y.;Tsai Y.-C.;Yu H.-J.;Pu Y.-S.; Chen C.-H.; Shun C.-T.; KUO-HOW HUANG; Huang C.-Y.; Tsai Y.-C.; Yu H.-J.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:03:44Z |
Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer
|
Lin C.-C.; Hsu C.-H.; Cheng J.C.; Huang C.-Y.; Tsai Y.-C.; Hsu F.-M.; KUO-HOW HUANG; Cheng A.-L.; Pu Y.-S. |
| 臺大學術典藏 |
2021-01-28T02:03:33Z |
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells
|
KUO-HOW HUANG; Kuo K.-L.; Chen S.-C.; Weng T.-I.; Chuang Y.-T.; Tsai Y.-C.; Pu Y.-S.; Chiang C.-K.; Liu S.-H. |
| 臺大學術典藏 |
2021-01-28T02:03:30Z |
Comparison of 24-h Urinary Aldosterone Level and Random Urinary Aldosterone-to-Creatinine Ratio in the Diagnosis of Primary Aldosteronism
|
Wu C.-H.;Yang Y.-W.;Hu Y.-H.;Tsai Y.-C.;Kuo K.-L.;Lin Y.-H.;Hung S.-C.;Wu V.-C.;Wu K.-D.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Kuo-How Huang;Chen Y.-M.;Kuo C.-C.;Chang C.-C.;Chueh S.-C.;Lu C.-C.;Liao S.-C.;Yen R.-F.; Wu C.-H.; Yang Y.-W.; Hu Y.-H.; Tsai Y.-C.; Kuo K.-L.; Lin Y.-H.; Hung S.-C.; Wu V.-C.; Wu K.-D.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; KUO-HOW HUANG; Chen Y.-M.; Kuo C.-C.; Chang C.-C.; Chueh S.-C.; Lu C.-C.; Liao S.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-01-28T02:03:22Z |
MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies
|
Kuo K.-L.;Ho I.-L.;Shi C.-S.;Wu J.-T.;Lin W.-C.;Tsai Y.-C.;Chang H.-C.;Chou C.-T.;Hsu C.-H.;Hsieh J.-T.;Chang S.-C.;Pu Y.-S.;Kuo-How Huang; Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; Lin W.-C.; Tsai Y.-C.; Chang H.-C.; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; Pu Y.-S.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:03:21Z |
Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma
|
Hu C.-Y.; Tsai Y.-C.; Wang S.-M.; Huang C.-Y.; Tai H.-C.; Chen C.-H.; Pu Y.-S.; Lin W.-C.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:03:19Z |
Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population
|
Wu V.-C.; KUO-HOW HUANG; Peng K.-Y.; Tsai Y.-C.; Wu C.-H.; Wang S.-M.; Yang S.-Y.; Lin L.-Y.; Chang C.-C.; Lin Y.-H.; Lin S.-L.; Chu T.-S.; Wu K.-D. |
| 臺大學術典藏 |
2021-01-28T02:03:18Z |
MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma
|
Ho I.-L.;Kuo K.-L.;Liu S.-H.-.;Chang H.-C.;Hsieh J.-T.;Wu J.-T.;Chiang C.-K.;Lin W.-C.;Tsai Y.-C.;Chou C.-T.;Hsu C.-H.;Pu Y.-S.;Shi C.-S.;Kuo-How Huang; Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; Chang H.-C.; Hsieh J.-T.; Wu J.-T.; Chiang C.-K.; Lin W.-C.; Tsai Y.-C.; Chou C.-T.; Hsu C.-H.; Pu Y.-S.; Shi C.-S.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:58Z |
dBRWD3 Regulates Tissue Overgrowth and Ectopic Gene Expression Caused by Polycomb Group Mutations
|
Shih H.-T.; Chen W.-Y.; Liu K.-Y.; Shih Z.-S.; Chen Y.-J.; Hsieh P.-C.; Kuo K.-L.; KUO-HOW HUANG; Hsu P.-H.; Liu Y.-W.; Chan S.-P.; Lee H.-H.; Tsai Y.-C.; Wu J.-T. |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Risk of sepsis in patients with primary aldosteronism 11 Medical and Health Sciences 1103 Clinical Sciences
|
Chan C.-K.;Hu Y.-H.;Chen L.;Chang C.-C.;Lin Y.-F.;Lai T.-S.;Kuo-How Huang;Lin Y.-H.;Wu V.-C.;Wu K.-D.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Chang C.-H.;Chang Y.-L.;Tsai Y.-C.;Yu C.-C.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Wang S.-M.;Liao S.-C.;Lu C.-C.;Yen R.-F.; Chan C.-K.; Hu Y.-H.; Chen L.; Chang C.-C.; Lin Y.-F.; Lai T.-S.; KUO-HOW HUANG; Lin Y.-H.; Wu V.-C.; Wu K.-D.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Wang S.-M.; Liao S.-C.; Lu C.-C.; Yen R.-F. |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:48Z |
Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism
|
Kuo-How Huang;Yu C.-C.;Hu Y.-H.;Chang C.-C.;Chan C.-K.;Liao S.-C.;Tsai Y.-C.;Jeff Chueh S.-C.;Wu V.-C.;Lin Y.-H.;Lin J.-H.;Wang W.-J.;Wu C.-H.;Er L.K.;Chang C.-H.;Chang Y.-L.;Ho Y.-L.;Chang H.-W.;Lin L.-Y.;Hu F.-C.;Liu K.-L.;Wang S.-M.;Lu C.-C.;Yen R.-F.;Wu K.-D.;Taipai, Taiwan Primary Aldosteronism Investigator; KUO-HOW HUANG; Yu C.-C.; Hu Y.-H.; Chang C.-C.; Chan C.-K.; Liao S.-C.; Tsai Y.-C.; Jeff Chueh S.-C.; Wu V.-C.; Lin Y.-H.; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.K.; Chang C.-H.; Chang Y.-L.; Ho Y.-L.; Chang H.-W.; Lin L.-Y.; Hu F.-C.; Liu K.-L.; Wang S.-M.; Lu C.-C.; Yen R.-F.; Wu K.-D.; TAIPAI, Taiwan Primary Aldosteronism Investigator |
| 臺大學術典藏 |
2021-01-28T02:02:46Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
